Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
HART Stock Summary
Top 10 Correlated ETFs
In the News
Rising Pharma Prices Could Give a Beat to HART ETF
Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some popular drugs with pharmaceutical companies.
Can Health Care Stocks Outperform Again In 2023?
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Healthcare Could Be a Healthy Sector Bet in 2023
The healthcare sector, the second-largest sector allocation in the S&P 500, performed significantly less poorly than the broader market in 2022 and that relative sturdiness has some market observers optimistic about the group's 2023 prospects.
Reliability Carried the Day for Healthcare Sector in 2022
With just two trading days left in 2022, it's safe to say the healthcare sector was significantly less bad than the broader market. As of December 27, the S&P 500 Health Care Index was down just 2.2% year-to-date compared to nearly 19% for the S&P 500.
HART Heavy on Healthcare Bounce Back Plays
With compelling long-term opportunities available across multiple industry groups, healthcare has the makings of a 2023 redemption, potentially boding well for exchange traded funds such as the IQ Healthy Hearts ETF (HART).
Healthcare Could Be Healthy 2023 Sector Bet
The defensive healthcare sector is living up to its billing this year, as the S&P 500 Health Care Index is lower by just 0.72% compared to 15.37% for the S&P 500.
HART Helpful for Avoiding Healthcare ESG Issues
On the surface, healthcare appears to be a sector with obvious environmental, social, and governance (ESG) credentials, meaning it's not surprising the group is prominent in an array of ESG exchange traded funds. However, healthcare isn't “ESG perfect.
FDA Rebound Could Help HART Beat Higher
Experienced healthcare investors know that the Food & Drug Administration (FDA) often looms large. After all, that is the regulatory body that has the final say in whether or not biotechnology and pharmaceutical companies can bring drugs to market.
HART Helpful Idea for Healthcare Defense
The healthcare sector is in the red this year, but its defensive traits are helping the group sharply outperform the broader market. That could be an encouraging sign for healthcare exchange traded funds, including the IQ Healthy Hearts ETF (HART).
HART Beat to Practical Healthcare ETF
Investors looking to capitalize on the healthcare sector's defensive and quality traits while contributing to the greater good have an appealing idea thanks to the IQ Healthy Hearts ETF (HART). HART is one of the Dual Impact exchange traded funds from New York Life Investments (NYLIM).
HART Financial details
HART Financial Performance
HART Frequently Asked Questions
What is IQ Healthy Hearts ETF stock symbol ?
IQ Healthy Hearts ETF is a US stock and trading under the symbol HART
What is IQ Healthy Hearts ETF stock quote today ?
IQ Healthy Hearts ETF stock price is $27.0861 today.
Is IQ Healthy Hearts ETF stock public?
Yes, IQ Healthy Hearts ETF is a publicly traded company.